Approval · Notice of Compliance 37547 · 2026
ELIGARD: Notice of Compliance 37547
Issued May 13, 2026
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 37547
- Date
- May 13, 2026
- Company
- Tolmar International Ltd.Dublin, Dublin, Ireland
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Addition of a manufacturing site and/or manufacturer involving production of the drug substance. Addition of a drug product manufacturing site and/or manufacturer involving production. Update to package labels.
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| ELIGARD | Not yet assigned | — |
Medicinal ingredients
- LEUPROLIDE ACETATE 7.5 MG per SYR
- LEUPROLIDE ACETATE 22.5 MG per SYR
- LEUPROLIDE ACETATE 30 MG per SYR
- LEUPROLIDE ACETATE 45 MG per SYR